ClinicalTrials.gg
Enrolling by invitationNCT06906419Updated May 14, 2025

Arthroscopic Trochleaplasty in Chronic Relapsing Patellar Dislocations: A Follow-up Study

An observational study in Patellar Dislocation, sponsored by Vestre Viken Hospital Trust. Enrolling by invitation at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-14.

Sponsored by Vestre Viken Hospital Trust · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the long-term clinical outcomes of arthroscopic trochleoplasty in patients treated for chronic recurrent patellar dislocations. The primary objective is to assess the effectiveness of the procedure in reducing the need for re-operations and preventing recurrent instability. Secondary objectives include evaluating postoperative complications, patellofemoral pain, functional outcomes using the Kujala Anterior Knee Pain Scale (AKPS), and quality of life measured by EQ-5D-5L. This retrospective cohort study will analyze data from patient records and structured telephone interviews conducted at least one year post-surgery.

02

Conditions studied

  • Patellar Dislocation

Browse trials for

Keywords

  • patellar dislocation
  • arthroscopic
  • trochleaplasty
03

In context

Patellar Dislocation

41 studies on the registry are indexed under Patellar Dislocation; 9 are open to participants now.

This study's planned enrollment of 20 is below the median of 100 across 15 observational studies indexed under Patellar Dislocation.

Browse Patellar Dislocation studies →

Lead sponsor

Vestre Viken Hospital Trust is the lead sponsor of 52 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This retrospective cohort study evaluates the long-term outcomes of arthroscopic trochleoplasty performed to stabilize the patella in patients with chronic recurrent dislocations. The procedure involves deepening the trochlea femoris to enhance patellar tracking and prevent lateral dislocation. In some cases, medial patellofemoral ligament (MPFL) reconstruction was also performed. Data will be collected through patient medical records and structured telephone interviews, focusing on re-operation rates, postoperative complications, pain levels, functional outcomes, and quality of life. The study seeks to provide insights into the effectiveness and safety of this surgical technique, aiming to optimize treatment protocols for patellar instability.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years and older.
  • Underwent arthroscopic trochleoplasty for chronic recurrent patellar dislocations.
  • Surgery performed between 2015 and 2023.
  • Availability of follow-up data and consent for participation.

Exclusion criteria

Exclusion Criteria:

  • Concurrent knee surgeries unrelated to trochleoplasty.
  • Previous surgeries on the same knee.
  • Other significant orthopedic conditions affecting the knee.
  • Lack of follow-up data or consent.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
20 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Re-operation Rate

    Proportion of patients requiring additional surgical interventions after the index surgery at our institution.

    Time frame: The investigators seek to register any re-operations from the time between the index surgery and the interview, ranging from 1 year up to 7 years postoperatively.

Secondary outcomes

  1. Recurrent Instability Rate

    Incidence of recurrent patellar dislocations post-surgery.

    Time frame: The investigators seek to register any incidences of recurrent instability from the time between the index surgery and the interview, ranging from 1 year up to 7 years postoperatively.

  2. Postoperative Complications

    Frequency and type of complications following trochleoplasty.

    Time frame: The investigators seek to register any complications related to the index surgery from the time between the index surgery and the interview, ranging from 1 year up to 7 years postoperatively.

  3. Functional Outcome

    Kujala Anterior Knee Pain Scale (AKPS) scores assessing pain and knee function. The Kujala Score or Anterior Knee Pain Scale (AKPS) is a 13-item self-report questionnaire that assesses subjective reactions to particular activities and symptoms that are known to correlate with anterior knee pain syndrome. The AKPS is graded on a scale of 0 to 100, with 100 being the highest possible score. Lower scores reflect greater pain and disability.

    Time frame: At the time of the interview, which will be performed from 1 year up to 7 years postoperatively.

  4. EQ-5D-5L (HRQoL) scores

    EQ-5D-5L (HRQoL) scores evaluating general health and well-being. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    Time frame: At the time of the follow-up interview, which will be performed from 1 year up to 7 years postoperatively.

  5. Pain Assessment

    Numeric pain rating scale (NRS), ranging from the least pain, 0, to the worst pain imaginable, 10, during daily activities.

    Time frame: At the time of the follow-up interview, which will be performed from 1 year up to 7 years postoperatively.

  6. Patient Satisfaction

    Satisfaction score on a scale, ranging from 1 (very dissatisfied) to 5 (very satisfied).

    Time frame: At the time of the follow-up interview, which will be performed from 1 year up to 7 years postoperatively.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06906419
Lead sponsor
Vestre Viken Hospital Trust
Responsible party
Sponsor
First posted
Apr 2, 2025
Start date
May 1, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 14, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion